In this study, we for the first time showed that AP2 is an important transcription factor driving USP22 gene expression; and revealed an association of AP2 with USP22 in lung cancer tissues, suggesting AP2 may promotes the progression of lung adenocarcinoma partially via enhancing USP22 expression. The gene discussed is USP22; the disease is lung carcinoma.